Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin P...
Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
About this item
Full title
Author / Creator
Santos, Inês , Ramos, Cristiano , Mendes, Cindy , Sequeira, Catarina O. , Tomé, Catarina S. , Fernandes, Dalila G.H. , Mota, Pedro , Pires, Rita F. , Urso, Donato , Hipólito, Ana , Antunes, Alexandra M.M. , Vicente, João B. , Pereira, Sofia A. , Bonifácio, Vasco D. B. , Nunes, Sofia C. and Serpa, Jacinta
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Ovarian cancer is the main cause of death from gynecological cancer, with its poor prognosis mainly related to late diagnosis and chemoresistance (acquired or intrinsic) to conventional alkylating and reactive oxygen species (ROS)-generating drugs. We and others reported that the availability of cysteine and glutathione (GSH) impacts the mechanisms...
Alternative Titles
Full title
Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6836284
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6836284
Other Identifiers
ISSN
2072-6643
E-ISSN
2072-6643
DOI
10.3390/nu11102523
